Bonds Amber C, Yuan Tianao, Werman Joshua M, Jang Jungwon, Lu Rui, Nesbitt Natasha M, Garcia-Diaz Miguel, Sampson Nicole S
Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York 11794-8651.
Department of Chemistry, Stony Brook University, Stony Brook, New York 11794-3400.
ACS Infect Dis. 2020 Aug 14;6(8):2214-2224. doi: 10.1021/acsinfecdis.0c00329. Epub 2020 Jul 27.
Cholesterol is a major carbon source for () during infection, and cholesterol utilization plays a significant role in persistence and virulence within host macrophages. Elucidating the mechanism by which cholesterol is degraded may permit the identification of new therapeutic targets. Here, we characterized EchA19 (Rv3516), an enoyl-CoA hydratase involved in cholesterol side-chain catabolism. Steady-state kinetics assays demonstrated that EchA19 preferentially hydrates cholesterol enoyl-CoA metabolite 3-oxo-chol-4,22-diene-24-oyl-CoA, an intermediate of side-chain β-oxidation. In addition, succinyl-CoA, a downstream catabolite of propionyl-CoA that forms during cholesterol degradation, covalently modifies targeted mycobacterial proteins, including EchA19. Inspection of a 1.9 Å resolution X-ray crystallography structure of EchA19 suggests that succinylation of Lys132 and Lys139 may perturb enzymatic activity by modifying the entrance to the substrate binding site. Treatment of EchA19 with succinyl-CoA revealed that these two residues are hotspots for succinylation. Replacement of these specific lysine residues with negatively charged glutamate reduced the rate of catalytic hydration of 3-oxo-chol-4,22-diene-24-oyl-CoA by EchA19, as does succinylation of EchA19. Our findings suggest that succinylation is a negative feedback regulator of cholesterol metabolism, thereby adding another layer of complexity to physiology in the host. These regulatory pathways are potential noncatabolic targets for antimicrobial drugs.
胆固醇是感染期间()的主要碳源,胆固醇的利用在宿主巨噬细胞内的持续存在和毒力方面发挥着重要作用。阐明胆固醇降解的机制可能有助于识别新的治疗靶点。在这里,我们对EchA19(Rv3516)进行了表征,它是一种参与胆固醇侧链分解代谢的烯酰辅酶A水合酶。稳态动力学分析表明,EchA19优先水合胆固醇烯酰辅酶A代谢物3-氧代胆固醇-4,22-二烯-24-酰基辅酶A,这是侧链β-氧化的中间体。此外,琥珀酰辅酶A是胆固醇降解过程中形成的丙酰辅酶A的下游分解代谢物,它共价修饰靶向的分枝杆菌蛋白,包括EchA19。对EchA19分辨率为1.9 Å的X射线晶体学结构的检查表明,Lys132和Lys139的琥珀酰化可能通过修饰底物结合位点的入口来干扰酶活性。用琥珀酰辅酶A处理EchA19表明,这两个残基是琥珀酰化的热点。用带负电荷的谷氨酸取代这些特定的赖氨酸残基降低了EchA19对3-氧代胆固醇-4,22-二烯-24-酰基辅酶A的催化水合速率,EchA19的琥珀酰化也是如此。我们的研究结果表明,琥珀酰化是胆固醇代谢的负反馈调节因子,从而为宿主生理学增加了另一层复杂性。这些调节途径是抗菌药物潜在的非分解代谢靶点。